SONOMA PHARMACEUTICALS, INC. Deferred Foreign Income Tax Expense (Benefit)
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Deferred Foreign Income Tax Expense (Benefit) of $270.00 thousand for the 12-month period ending 2026-03-31, per its 10-K filed 2026-06-16.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2026-06-16
- SONOMA PHARMACEUTICALS, INC. deferred foreign income tax expense (benefit) for fiscal 2026 was $270.00K.
- SONOMA PHARMACEUTICALS, INC. deferred foreign income tax expense (benefit) for fiscal 2025 was -$548.00K, a 376.77% decline from fiscal 2024.
- SONOMA PHARMACEUTICALS, INC. deferred foreign income tax expense (benefit) for fiscal 2024 was $198.00K.
- SONOMA PHARMACEUTICALS, INC. deferred foreign income tax expense (benefit) for fiscal 2023 was -$35.00K.
| Period end | Deferred Foreign Income Tax Expense (Benefit) 12 month | Deferred Foreign Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2026-03-31 | $270.00K 10-K · filed 2026-06-16 | |
| 2025-03-31 | -$548.00K 10-K · filed 2026-06-16 | |
| 2024-03-31 | $198.00K 10-K · filed 2025-06-17 | -$198.00K 10-K · filed 2024-06-17 |
| 2023-03-31 | -$35.00K 10-K · filed 2024-06-17 | |
| 2022-03-31 | -$809.00K 10-K · filed 2023-06-21 | |
| 2021-03-31 | $0.00 10-K · filed 2022-07-13 | |
| 2020-03-31 | $0.00 10-K · filed 2021-07-14 | |
| 2019-03-31 | $0.00 10-K · filed 2020-07-10 | |
| 2018-03-31 | $0.00 10-K · filed 2019-07-01 | |
| 2017-03-31 | -$844.00K 10-K · filed 2018-06-26 | |
| 2016-03-31 | $0.00 10-K · filed 2017-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |